Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer

This study has been completed.
Sponsor:
Collaborator:
Synta Pharmaceuticals Corp.
Information provided by (Responsible Party):
Bassel El-Rayes, Emory University
ClinicalTrials.gov Identifier:
NCT01554969
First received: March 13, 2012
Last updated: February 19, 2016
Last verified: February 2016